Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Reusable catheters a safe choice that could save NHS millions, study finds

Written by | 30 May 2026

Reusable catheters are just as safe for patients as single-use ones and do not increase the risk of urinary tract infections, a new study has found. Thousands of… read more.

Community-based baby hip screening reduces late diagnosis

Written by | 30 May 2026

Nurse-led, community-based ultrasound screening for hip dysplasia achieved almost universal reach and identified children earlier than current practices. A University of Tokyo study found that 8.7% of infants… read more.

FDA approves Ocrevus (ocrelizumab) IV infusion for relapsing-remitting multiple sclerosis in pediatric patients aged 10 years and older – Genentech

Written by | 30 May 2026

Genentech has received FDA approval of Ocrevus (ocrelizumab) intravenous (IV) infusion for the treatment of relapsing-remitting multiple sclerosis (RRMS) in pediatric patients 10 years of age and older who… read more.

Nearly 10% of surgeons are leaving the profession within 8 years

Written by | 29 May 2026

Surgeons are an integral part of the health care system, supplying critical and urgent care in nearly every field of medicine. But surgeons are already in short supply,… read more.

UK heat risk leaves vulnerable people dangerously exposed

Written by | 29 May 2026

Older people, care home residents and those living in poor-quality housing are facing growing danger from extreme heat, as new research warns that the UK is failing to… read more.

Positive topline results from the Phase 3 MagnetisMM-5 study evaluating Elrexfio (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma – Pfizer

Written by | 29 May 2026

Pfizer announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating Elrexfio (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who received at… read more.

Do advance directives affect end-of-life care?

Written by | 28 May 2026

Advance directives document patient preferences for future care, including end-of-life. An analysis in the Journal of the American Geriatrics Society found that older patients with an advance directive that had… read more.

Private equity acquisition can expand primary care use by expanding workforce, study finds

Written by | 28 May 2026

When health policy researchers at the Brown University School of Public Health tracked data from primary care practices that had been acquired by private equity firms, they found… read more.

FDA approves Baxfendy (baxdrostat) as the first and only aldosterone synthase inhibitor treatment for adults with hypertension – AstraZeneca

Written by | 28 May 2026

AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to… read more.

Tirzepatide appears to be more effective than standard care in early type 2 diabetes

Written by | 27 May 2026

Researchers report that early treatment of type 2 diabetes with tirzepatide leads to greater improvements over 2 years in blood sugar, body weight, and waist size than treatment… read more.

Common food preservatives linked to high blood pressure and heart disease

Written by | 27 May 2026

Eating foods that contain common preservative food additives may increase the risks of high blood pressure and cardiovascular disease, according to research published in the European Heart Journal [1] today… read more.

Clinical information – the bridge between operational and digital healthcare

Written by | 27 May 2026

Ramandeep Kaur did not plan a career in digital health. In 2014, newly arrived at Leicester Royal Infirmary as a locum pharmacist, she spotted a job advertisement related… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.